AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVAX
  4. [6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)

[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock EVAX logo
Evaxion AS

NASDAQ:EVAX

EVAX Rankings

#9216 Ranked by Market Cap
N/A Ranked by Dividends

EVAX Latest News

Aug 11, 2025
Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025
Jul 25, 2025
Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
Jul 11, 2025
Evaxion finalizes agreement with EIB to convert debt into equity
Jul 1, 2025
Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology� platform and portfolio
Jun 25, 2025
Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

EVAX Latest SEC Filings

Aug 11, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)
Jul 25, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)
Jul 11, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)
Jul 2, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)
Jun 25, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)

EVAX Stock Data

17.88M
4.86M
23.07%
7.07%
1.66%
Biotechnology
Healthcare
Denmark
Horsholm